Sitemap - 2025 - The Billion Dollar Blindspot
The Signals I’m Watching in Women’s Health as 2026 Approaches
What 2025 Taught Investors About Healthcare
Why Women’s Health and Women’s Wealth Are Not Separate Conversations
What Women Already Knew About Telehealth
The Most Dangerous Myth in Medicine: The Average Patient
The 150-Minute Myth: Why Women’s Hearts Were Never Playing by the Rules
Tough Love for Women’s Health Founders
When Care Becomes Capital: Inside the $18 Billion Women’s Health Deal Reshaping Medicine
The Billion Dollar Blind Spot: Why We Built the FemmeHealth Alliance
Being Female Is Not a Disease: The Untapped Investment Opportunity in Women’s Health
Why Gender Medicine Matters for Investors
The Business of Women's Health
The Silent Ban: How Social Media Is Censoring Women’s Health
What Can’t Be Printed Away: Hard Assets and the Future of Women’s Health
From a mobile clinic in Africa to hospitals in the West - How permission, power and care collide
She Coined ‘FemTech’. Now She’s Rewriting the Narrative on Women’s Health
Why Women Investors Outperform Men and What Wall Street Still Doesn’t See
When the System Fails: What Concierge Medicine Reveals About Female Longevity
Should Every Woman Be on Hormone Therapy?
Why Most Digital Health Startups Will Fail
The Future of Female Longevity
The $600 Billion Blindspot: Why Menopause is the Next Big Bet in Longevity
Why Viagra Was Fast-Tracked And Women’s Hormones Were Left Behind
What Real Science in Women’s Health Looks Like
Gates’ $2.5 Billion Women’s Health Bet: Will Private Capital Be Ready to Catch It?
The Silent Punishment of Midlife Women at Work
Is It Brain Fog or Just Dopamine?
A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis
Why Innovation in Women’s Health Still Lags And What Needs to Change
The Midlife Vanishing: Why Women Are Quietly Leaving and No One’s Asking Why
Why Longevity Tech Is Failing Women Over 40
Alliance Spotlight — Dr. Maria Fay
Longevity Misses the Mark: Why Menopause Is the Blind Spot in Aging Science
Why Erectile Dysfunction Gets Funded and Women’s Health Gets Dismissed
Even Venus Wasn’t Believed: The Hidden Cost of Delayed Diagnosis in Women’s Health
Biotech or Branding? How to Spot Real Science in Women’s Health
The Market They Said Didn’t Exist And Why I Built Anyway
Fake Science in Femtech: 3 Ways to Spot Red Flags Before You Buy
The Hidden Reason Promising Women’s Health Startups Fail
The Trillion-Dollar AI Correction
What Investors Still Cannot See And Where the Alpha Is Hiding
The Book I Wish I’d Had: A Strategic Guide to Investing in Women’s Health Innovation
Signal Not Noise: Clarity’s FDA Win, Progyny x Amazon, and the Rise of Hormone Health Infrastructure
Strategic Collaboration Announced: FHV Alliance x FemTech Weekend
Menstrual Fatigue Relief: How Pharmalp’s Femina Cycles Is Quietly Innovating Women's Health
The Quiet Reason Women Aren’t Investing
Why Women Don’t Invest And Why That’s Changing Now
Signal Not Noise: Flo’s Data Reckoning, Evvy’s Expansion & Toxic Tampons Wake Up the Market
How to Use Your Roth IRA to Start Investing in Women’s Health
Why Women’s Health Gets Overlooked And What Investors Are Missing
Signal Not Noise: Hologic’s Bet, Hormona’s Raise & Insurance-Backed Longevity for Women
How to Start Angel Investing in Women’s Health with Just $1K
Why Women’s Health Is Still Underfunded and What Smart Investors Are Doing About It
Signal Not Noise: What Mattered in Women’s Health Investing (May 11–May 17)
The 1,000-Day Fix: Nina Kumari’s Case Against “Good Enough” Formula
Postpartum Isn’t a Niche. It’s Infrastructure
Signal Not Noise: What Mattered in Women’s Health Investing (May 4–May 10)
The Real Moat in Women’s Health Isn’t What You Think
Why Menopause Care Is the New Fertility: A Strategic Shift Investors Are Missing
Signal Not Noise: What Mattered in Women’s Health Investing (Apr 27–May 3)
5 Trends That Prove Reproductive Health is a Macro Opportunity
Signal Not Noise: What Mattered in Women’s Health Investing (Apr 20–26)
Episode #6: This Startup Is Changing the Way We Detect Cervical Cancer
Capital Meets Care: Q1 2025 Momentum Report from FemmeHealth Ventures Alliance
Signal Not Noise: What Mattered in Women’s Health Investing (Apr 14–19)
Why Continuous Hormone Monitoring Could Be a Game-Changer in Women’s Health and Fertility Innovation
Signal Not Noise: What Mattered in Women’s Health Investing (Apr 7–14)
The Cost of Waiting: Why Women’s Health Delays Are a Trillion-Dollar Problem
Signal Not Noise: This Week in Women’s Health Investing (Mar 30–Apr 6)
What do sweeping U.S. tariffs have to do with biotech, women’s health or innovation strategy?
With U.S. Funding Faltering, Europe May Be the Next Hub for Life Sciences Innovation
When Progesterone Leaks, So Does Hope. One UK Startup Wants to Change That
What the Elvie-Willow Deal Really Means for the Future of Femtech
So You Want to Invest in Women’s Health? Start Here
The Autoimmune Gender Gap: 10 Private Companies Advancing Women’s Health
Episode #5: Transforming PostPartum Care with AI
How Investors Can Build Profitable, Scalable Women’s Health Solutions
The $1 Trillion Investment Opportunity in Women’s Health: What You Need to Know
Women’s Health is Mispriced And That’s a Multi-Billion Dollar Problem
Femtech’s $1 Trillion Opportunity: Why Investors Are Watching Virtual Women’s Health
How Digital Censorship is Hurting Women’s Health Startups—And What Investors Need to Know
How Angel Investors Shape the Future—A Conversation with Annamaria Tartaglia
How to Build Wealth as a Woman—Even If You’re a Caregiver
The Unapologetic Truth About Getting Fit After 40
VC Funding for Women’s Health Drops—But the Market Is Bigger Than Ever
Understanding the Women's Health Market Size
How to Stay at Sub-19% Body Fat in Your 40s Without Extreme Dieting
How Lifting a 3kg Dumbbell Changed My Life
How Angel Investors Shape the Future—A Conversation with Steffen Ehrhardt
Beyond Hot Flashes: Investing in the Next Wave of Menopause Innovation
Why Women’s Health is the Next Big Opportunity for Angel Investors
Can Angel Investing Fuel the Future of Women's Health?
Episode #4: Breaking Barriers in Drug Delivery for Women